<DOC>
	<DOC>NCT02369497</DOC>
	<brief_summary>This is a prospective study on the Ascension HRA device to collect data to assess the safety and effectiveness of the HRA.</brief_summary>
	<brief_title>Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study</brief_title>
	<detailed_description>This study protocol will provide guidance to investigators wanting to perform a non-randomized, consecutive enrollment, 10-year follow-up study of patients who are treated with the Ascension® HRA. Its purpose is to measure and document the outcomes associated with implanting the Ascension HRA prosthesis. Patients will be periodically assessed to collect data related to safety and effectiveness endpoints at the following intervals: preoperative, surgery/immediate post-op, 3 months, 6 months, 1 year, 2 year, 5 year, and 10 years.</detailed_description>
	<criteria>Any patient who is to be treated with the Ascension HRA is eligible for inclusion in this study. Therefore, Principal Investigators should attempt to recruit all patients at the study site who are treated with the Ascension HRA The following patient will be included in the study Patient who: Is treated with the Ascension HRA Is disabled by either noninflammatory or inflammatory arthritis (i.e. rheumatoid arthritis, osteoarthritis and avascular necrosis Has mild or moderate humeral head deformity and /or limited motion Has posttraumatic arthritis Has an intact or reparable rotator cuff Has the means and ability to return for all required study visits Is willing to participate in the study Has signed an Informed Consent Form Is at least 18 years of age and skeletally mature at the time of surgery Is less than 75 years of age at the time of surgery Infection, sepsis, and osteomyelitis Osteoporosis Metabolic disorders which may impair bone formation Osteomalacia Rapid joint destruction, marked bone loss or bone resorption apparent on Xray Revision procedures where other devices or treatments have failed Refuses to be in the study; or does not have the means and ability to return for all required study visits Currently participating in another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>